Dyne Therapeutics maintains a strong $1.1B cash position, funding operations into mid-2028 despite heavy R&D and operating ...

Q4 2025 earnings call recap: pemvidutide Phase III MASH plans, Phase II data, FDA status, cash runway to 2028—read now.

NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage biotechnology company developing transformative therapies for the treatment of cancer and rare ...

Now looking beyond NASH, PEMB has the potential to address major unmet medical needs in both AUD and ALD because of a similar ...

PureWow editors select every item that appears on this page, and some items may be gifted to us. Additionally, PureWow may ...

The GMO Quality Strategy focuses its investments on companies with proven cash flows, differentiation, barriers to entry that enable high returns on investment, and strong balance sheets. As we ...

A 2026 informational consumer evaluation examining Karylief’s hearing health supplement marketing claims, ingredient research ...

Introduction Older adult loneliness is associated with depression, disability and higher mortality rates. As a public health concern, it contributes to increased medical and nursing care costs.